Daiichi Sankyo
Suresh Sampath is an accomplished professional in data architecture and informatics, currently serving as Data Architecture leader at Daiichi Sankyo, Inc. since January 2024. Previously, Suresh held the position of Director of Data Architecture at PPD, where responsibilities included developing data, integration, and analytics strategies for Decentralized Clinical Trials, as well as architecting end-to-end data pipelines. Prior experience at Quest Diagnostics encompassed the development of enterprise-level data and analytics strategies, leading modernization efforts into AWS Cloud, and establishing data architecture best practices. Suresh's extensive career also includes roles at Bristol-Myers Squibb, Pfizer, Merck, and DSQ Software Limited, covering database design, ETL processes, and software development. Educational qualifications include an MBA in Technology Management from Stevens Institute of Technology and a Bachelor of Engineering in Computer Science & Engineering from Annamalai University.
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.